Amphastar Pharmaceuticals, Inc.AMPHNASDAQ
Loading
Interest Expense Over TimeContracting
Percentile Rank86
3Y CAGR+139.9%
5Y CAGR+132.6%
Studio
Year-over-Year Change

Interest expense on outstanding debt

3Y CAGR
+139.9%/yr
vs +66.0%/yr prior
5Y CAGR
+132.6%/yr
Recent acceleration
Acceleration
+73.9pp
Accelerating
Percentile
P86
Within normal range
vs 5Y Ago
68.1x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$25.48M-16.0%
2024$30.34M+11.7%
2023$27.16M+1371.2%
2022$1.85M+108.6%
2021$885000.00+136.6%
2020$374000.00+214.3%
2019$119000.00-51.0%
2018$243000.00-70.6%
2017$826000.00-19.3%
2016$1.02M-